Medical/Pharmaceuticals

Mundipharma Enters Partnership With Samsung Bioepis to Expand Biosimilars Into Hong Kong and Taiwan

SINGAPORE, Jan. 13, 2020 /PRNewswire/ -- Mundipharma today announced a partnership with Samsung Bioepis to commercialize Samsung Bioepis' first-wave biosimilar candidates inTaiwan and Hong Kong. The partnership covers Samsung Bioepis' biosimilar candidates in the field of immunology and oncology...

2020-01-13 10:02 520

Skyrocketing growth tipped for China Medical industry over next 5 years; Medtec China 2020 upgrades to two halls to meet market needs

SHANGHAI, Jan. 13, 2020 /PRNewswire/ -- According to a forecast from CIConsulting, the revenue ofChina's medical equipment and manufacturing industry will reachCNY327.4 billion in 2019, the average annual compound growth rate over the next five years will be about 8.15%, and the market will reach...

2020-01-13 09:00 536

Seneca Biopharma Announces Presentations at Both Sachs Associates 3rd Annual Neuroscience Innovation Forum & Biotech Showcase™ 2020

GERMANTOWN, Maryland, Jan. 10, 2020 /PRNewswire/ -- Seneca Biopharma, Inc., (NASDAQ: SNCA), a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need, announced today thatSeneca's Executive Chairman,Ken Carter, will present at both Sachs Associates ...

2020-01-11 00:00 5649

VISTA Eye Specialist bringing vision correction to a whole breakthrough level of safety

KUALA LUMPUR, Malaysia, Jan. 10, 2020 /PRNewswire/ -- VISTA Eye Specialist (VISTA), one of the premier and largest eye specialist inMalaysia, announces the introduction of No-Blade ICL, a combination of the Ziemer LDV Z8 Femtosecond Laser and the Visian EVO ICL. Placed within the eye, the ICL hel...

2020-01-10 17:32 830

Cala Health Applauded by Frost & Sullivan for Revolutionizing the Essential Tremor Market with its Body-worn Neuromodulation Therapy, Cala Trio(TM)

SANTA CLARA, Calif., Jan. 9, 2020 /PRNewswire/ -- Based on its recent analysis of the North American essential tremor (ET) treatment market, Frost & Sullivan recognizes Cala Health, Inc. with the 2019 North American Technology Innovation Award for its Cala Trio™, a prescription-only, wrist-worn d...

2020-01-09 22:00 486

Alma, a Sisram Medical Company, Launches DermaClear 3-in-1 Skin Hydradermabrasion Platform

NUREMBERG, Germany, Jan. 9, 2020 /PRNewswire/ -- Alma, one of the top five global leaders of energy-based medical and aesthetic solutions, today announced the launch of DermaClear, a powerful 3-in-1 treatment solution for deep cleansing, nourishment, and hydration of facial skin.   DermaClear i...

2020-01-09 17:00 547

Alma, a Sisram Medical Company, Receives Excellence Award for "Outstanding Business Performance in Japan"

NURNBERG, Germany, Jan. 9, 2020 /PRNewswire/ -- Alma, one of the top five global leaders of energy-based medical and aesthetics solutions, today announced it has been recognized with an Excellence Award for its "outstanding business performance inJapan" in 2019. The annual "Excellence Award" was...

2020-01-09 10:00 680

Daewoong Infion obtained World's First Halal Certification for Biopharmaceutical Product Derived from Animal Cells

SEOUL, South Korea, Jan. 9, 2020 /PRNewswire/ -- Daewoong Infion Co. has achieved world's first halal certification for animal cells-derived biopharmaceuticals.  World's First Halal certification for Biopharmaceutical Product derived from An...

2020-01-09 09:51 610

Publication of a Toxicological Study: A Milestone for Jennewein Biotechnologie for the GRAS Approval of the HMO-mix

RHEINBREITBACH, Germany, Jan. 9, 2020 /PRNewswire/ -- Jennewein Biotechnology announces another milestone in the worldwide approval of a new product generation, the "HMO-Mix." The data of the toxicological study, with the title "A Safety Evaluation of Mixed Human Milk Oligosaccharides in Rats," w...

2020-01-09 02:26 593

Symmetry Surgical, Inc. Acquires The O.R. Company

Acquisition strengthens Symmetry's commitment to deliver best-in-class, cost-effective solutions NASHVILLE, Tennessee, Jan. 9, 2020 /PRNewswire/ -- Symmetry Surgical, Inc. ("Symmetry"), is pleased to announce that it has completed its acquisition of The O.R. Company. The O.R. Company develops, m...

2020-01-09 00:37 452

Waters Corporation Lauded by Frost & Sullivan for Developing the First Truly Smart Mass Spectrometer, the BioAccord LC-MS System

The system was designed to enhance productivity, positioning the user to acquire and process data with a purpose-built LC-MS platform SANTA CLARA, California, Jan. 8, 2020 /PRNewswire/ -- Based on its analysis of the global biopharmaceutical analytical instrumentation market, Frost & Sullivan ...

2020-01-08 21:30 5535

Former Celgene Chairman and CEO Mark J. Alles Joins Antengene Board of Directors

SHANGHAI and PHILADELPHIA, Jan. 8, 2020 /PRNewswire/ -- The Antengene board today announced the appointment of Mr.Mark J. Alles as an independent director of the company, effectiveJanuary 2, 2020. Mr. Alles is the former Chairman and Chief Executive Officer of Celgene Corporation, now a subsidiar...

2020-01-08 20:00 1275

Connect Biopharma Reports Positive Topline Data from Moderate-to-severe Atopic Dermatitis (AD) Phase 1b Study of CBP-201

Data show superior efficacy after four weeks of treatment and more rapid onset of action for CBP-201 compared with data from studies of current standard of care therapy for AD On Day 29, 42.9% and 50.0% of patients receiving CBP-201 300 mg or 150 mg, respectively, achieved "clear/almost clear" s...

2020-01-08 19:00 360

CStone announces first patient dosed in the Phase III trial of CS1001 in combination with chemotherapy in first-line esophageal squamous cell carcinoma

SUZHOU, China, Jan. 8, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) announced that the first patient has been dosed in the Phase III GEMSTONE-304 study of the Company's anti-PD-L1 antibody CS1001 in combination therapy as first-line treatment in patients wit...

2020-01-08 13:45 1297

Daewoong Pharmaceutical Receives World's First Halal Certification for Biopharmaceutical Product Derived from Animal Cells through Indonesian Joint Venture, Daewoong Infion

SEOUL, South Korea, Jan. 8, 2020 /PRNewswire/ -- Daewoong Infion Co. has achieved world's first halal certification for animal cells-derived biopharmaceuticals. Daewoong Pharmaceutical Co., Ltd. (CEO Sengho Jeon) announced that Daewoong Infion, the company's joint venture with Infion, an In...

2020-01-08 11:00 335

Hummingbird Bioscience Publishes Preclinical Data Demonstrating Efficacy of HMBD-001 in HER3 Driven Cancers

* HER3 activation is implicated in tumor progression and in acquired resistance to EGFR and HER2 therapies * Study, published in Molecular Cancer Therapeutics, found HMBD-001 to be able to uniquely block HER3 dimerization interface and potently inhibit tumor growth SINGAPORE, Jan. 8, 2020 /PR...

2020-01-08 10:40 381

Rapid Diagnostics Announces Completion of Asset Purchase and New Corporate Strategies

LONDON, Jan. 8, 2020 /PRNewswire/ -- Rapid Diagnostics ML Limited, UK is pleased to announce the return of its Point of Care (PoC) platform, the MiniLab System. Rapid was formed to purchase the assets and Intellectual Property (IP) of the former Enigma Diagnostics, which was liquidated in 2017. ...

2020-01-08 08:00 473

Innovent and Sirnaomics Entered Strategic Collaboration to Conduct Clinical Oncology Studies Combining Sintilimab and RNAi in the US

SUZHOU, China, Jan. 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, and Sirnaomics Inc. ("Si...

2020-01-08 08:00 6768

Rising Demand for IoT-enabled Pumps to Drive North American PD Pumps Market amid Economic Slowdown

Integration of machine learning, artificial intelligence in pumps to help improve efficiency and reduce maintenance costs, finds Frost & Sullivan SANTA CLARA, California, Jan. 8, 2020 /PRNewswire/ -- Driven by continued investments in the US oil and gas industry, along with increased activity in ...

2020-01-08 06:03 364

Southstar Drug Gets Ready for the Future with Huawei Wi-Fi 6

MANILLA, Philippines, Jan. 7, 2020 /PRNewswire/ -- Recently, by choosing a wireless Wi-Fi-6 network from Huawei, Southstar Drug is able to operate its business more efficiently and at greater speed, with better access to resources,helping to boost employee productivity. Southstar Drug, a subsidi...

2020-01-08 00:01 392
1 ... 3456789 ... 148